Home

Večno poznat stog cyfra 21 1 marker gore Ulazak lavanda

PDF) CYFRA 21-1 as a tumour marker for bronchogenic carcinoma
PDF) CYFRA 21-1 as a tumour marker for bronchogenic carcinoma

researchopenworld.com
researchopenworld.com

Table 1 from Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour  marker for detecting disease relapse and assessing treatment efficacy in  breast cancer | Semantic Scholar
Table 1 from Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | Semantic Scholar

CanAg® CYFRA 21-1 EIA | Fujirebio
CanAg® CYFRA 21-1 EIA | Fujirebio

Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of  operable lung cancer from benign lung disease Chen F, Li J, Qi X, Qi J - J  Can Res Ther
Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease Chen F, Li J, Qi X, Qi J - J Can Res Ther

PDF) CYFRA 21-1 as a tumour marker for bronchogenic carcinoma
PDF) CYFRA 21-1 as a tumour marker for bronchogenic carcinoma

CYFRA 21-1 Serum Analysis in Patients with Esophageal Cancer | Clinical  Cancer Research
CYFRA 21-1 Serum Analysis in Patients with Esophageal Cancer | Clinical Cancer Research

PDF] Diagnostic Efficiency of HE 4 and CYFRA 21-1 in Patients with Lung  Cancer | Semantic Scholar
PDF] Diagnostic Efficiency of HE 4 and CYFRA 21-1 in Patients with Lung Cancer | Semantic Scholar

Elevation of cytokeratin 19 fragment (CYFRA 21-1) in serum of patients with  radiation pneumonitis: possible marker of epithelial cell damage -  Respiratory Medicine
Elevation of cytokeratin 19 fragment (CYFRA 21-1) in serum of patients with radiation pneumonitis: possible marker of epithelial cell damage - Respiratory Medicine

Relationship of CYFRA 21-1 to the histo- logical type of NSCLC and the... |  Download Scientific Diagram
Relationship of CYFRA 21-1 to the histo- logical type of NSCLC and the... | Download Scientific Diagram

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer:  results of a meta-analysis in 2063 patients | British Journal of Cancer
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer

Epithelial tumor markers
Epithelial tumor markers

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell  Lung Cancer in a Prospective Trial: CALGB 150304 - Journal of Thoracic  Oncology
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - Journal of Thoracic Oncology

A Novel Immunoassay for the Quantization of CYFRA 21–1 in Human Serum - He  - 2013 - Journal of Clinical Laboratory Analysis - Wiley Online Library
A Novel Immunoassay for the Quantization of CYFRA 21–1 in Human Serum - He - 2013 - Journal of Clinical Laboratory Analysis - Wiley Online Library

Cyfra 21-1 as a Biologic Marker of Non-small Cell Lung Cancer
Cyfra 21-1 as a Biologic Marker of Non-small Cell Lung Cancer

Cyfra 21-1 as a Serum Tumor Marker for Follow-up of Patients with Laryngeal  and Hypopharyngeal Squamous Cell Carcinoma | Anticancer Research
Cyfra 21-1 as a Serum Tumor Marker for Follow-up of Patients with Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | Anticancer Research

Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for  Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive  Partitioning Risk Stratification Analysis - ScienceDirect
Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis - ScienceDirect

Prognostic and predictive biomarkers in early stage NSCLC: CTCs and  serum/plasma markers - Crosbie - Translational Lung Cancer Research
Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers - Crosbie - Translational Lung Cancer Research

Cyfra 21-1 EIA July 2009 (2).pdf - Fujirebio Diagnostics, Inc.
Cyfra 21-1 EIA July 2009 (2).pdf - Fujirebio Diagnostics, Inc.

Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody  immune complex for detection of early stage lung cancer - Chemical  Communications (RSC Publishing)
Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer - Chemical Communications (RSC Publishing)

Table 2 from A COMPARISON OF CYFRA 21-1, NSE, AND CEA FOR THE SERODIAGNOSIS  OF LUNG CANCER | Semantic Scholar
Table 2 from A COMPARISON OF CYFRA 21-1, NSE, AND CEA FOR THE SERODIAGNOSIS OF LUNG CANCER | Semantic Scholar

CYFRA 21-1 DISTRIBUTION IN NON-SMALL CELL LUNG CANCER | Download Table
CYFRA 21-1 DISTRIBUTION IN NON-SMALL CELL LUNG CANCER | Download Table

Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in  advanced non-small cell lung cancer - Yoshimura - Translational Lung Cancer  Research
Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer - Yoshimura - Translational Lung Cancer Research

Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in  advanced non-small cell lung cancer - Yoshimura - Translational Lung Cancer  Research
Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer - Yoshimura - Translational Lung Cancer Research

Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict  objective response to chemotherapy in patients with non-small cell lung  cancer
Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer